These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13944106)

  • 1. Biological estimation of the intensity and duration of action of monoamine oxidase inhibitors.
    PLUMMER AJ; FURNESS PA
    Ann N Y Acad Sci; 1963 Jul; 107():865-77. PubMed ID: 13944106
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of reserpine and monoamine oxidase inhibitors on anaphylactic shock in mice].
    HALPERN BN; NEVEU T; BRANELLEC A; DRUDI-BARACCO C
    C R Seances Soc Biol Fil; 1962; 156():1739-43. PubMed ID: 13952223
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study, on gastric secretion, of the antagonism between reserpine and monoamine oxidase inhibitors (MAOI)].
    BONFILS S; DUBRASQUET M; LAMBLING A
    Gastroenterologia; 1962; 98():217-24. PubMed ID: 13968782
    [No Abstract]   [Full Text] [Related]  

  • 4. THE EFFECTS OF RESERPINE ON THE SPONTANEOUS CONTRACTION OF THE ISOLATED ATRIUM OF RABBIT TREATED WITH MONOAMINE OXIDASE INHIBITORS.
    TACHI S; NAKATANI G; FUJIWARA M
    Jpn J Pharmacol; 1963 Apr; 13():74-81. PubMed ID: 14065387
    [No Abstract]   [Full Text] [Related]  

  • 5. EFFECT OF VARIOUS MONOAMINE OXIDASE INHIBITORS ON THE CATECHOLAMINE CONTENT OF RAT HEART.
    BHAGAT B
    Arch Int Pharmacodyn Ther; 1963 Nov; 146():65-72. PubMed ID: 14078525
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE COMPOUNDS, MONOAMINE OXIDASE INHIBITORS AND D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    CAHN J; HEROLD M
    Agressologie; 1964; 5():451-63. PubMed ID: 14192331
    [No Abstract]   [Full Text] [Related]  

  • 7. The pressor effect of reserpine after monoamine-oxidase inhibitors.
    GARATTINI S; FRESIA P; MORTARI A; PALMA V
    Med Exp Int J Exp Med; 1960; 2():252-9. PubMed ID: 13703426
    [No Abstract]   [Full Text] [Related]  

  • 8. The depletion of catecholamine of the rabbit's atria by reserpine in vitro.
    MATSUO T
    Jpn J Pharmacol; 1962 Jun; 12():62-71. PubMed ID: 13933794
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE, A MONOAMINE OXIDASE INHIBITOR AND DIFFERENT D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    SOULAIRAC A; SOULAIRAC ML
    Agressologie; 1964; 5():465-71. PubMed ID: 14192332
    [No Abstract]   [Full Text] [Related]  

  • 10. CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION.
    MAXWELL MH; ROTH SI; GONICK HC; KLEEMAN CR
    Am Heart J; 1963 Aug; 66():151-63. PubMed ID: 14051181
    [No Abstract]   [Full Text] [Related]  

  • 11. Restoration of the chronotropic effect of tyramine on rat atria after reserpine.
    Murnaghan MF
    Br J Pharmacol; 1968 Sep; 34(1):88-98. PubMed ID: 4877602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of reserpine and iproniazid on Caratuis auratus L. activity].
    Deliège M
    C R Seances Soc Biol Fil; 1969 Apr; 162(10):1865-7. PubMed ID: 4238670
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H; SAWYER JL
    J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect upon the analgesic action of reserpine of central nervous system stimulants and drugs affecting the metabolism of catechol- and indole-amines.
    LEME JG; ROCHA E SILVA M
    J Pharm Pharmacol; 1963 Jul; 15():454-60. PubMed ID: 13929554
    [No Abstract]   [Full Text] [Related]  

  • 15. [EFFECT OF CHANGES IN MEDIATOR METABOLISM ON THE DEVELOPMENT OF HEART HYPERTROPHY].
    MEERSON FZ; ROZANOVA LS
    Biull Eksp Biol Med; 1964 Mar; 57():34-7. PubMed ID: 14185598
    [No Abstract]   [Full Text] [Related]  

  • 16. [PROBLEMS IN INTERPRETATION OF THE MECHANISM OF EFFECT OF PSYCHOPHARMACOLOGICAL AGENTS].
    VITEK V; RYSANEK K
    Act Nerv Super (Praha); 1964; 6():160-5. PubMed ID: 14164145
    [No Abstract]   [Full Text] [Related]  

  • 17. THE PHARMACOLOGY OF 3-PHENOXYPROPYLGUANIDINE.
    CHEN G; ENSOR CR; MCCARTHY DA; MCLEAN JR; CAMPBELL A
    J Pharmacol Exp Ther; 1964 Mar; 143():374-82. PubMed ID: 14161151
    [No Abstract]   [Full Text] [Related]  

  • 18. [ALPHA-METHYLDOPA DOES NOT INHIBIT THE SYNTHESIS AND STORAGE OF CATECHOLAMINES IN THE ADRENALS OF RAT].
    CLEMENTI F; FRESIA P; MORTARI A; SIOLI G
    Arch Int Pharmacodyn Ther; 1964 Nov; 152():179-87. PubMed ID: 14248344
    [No Abstract]   [Full Text] [Related]  

  • 19. [MECHANISM OF THE EMETIC EFFECT OF CATECHOLAMINES].
    CAHEN R; TAURAND S; PESSONNIER A
    C R Seances Soc Biol Fil; 1963 Aug; 157():774-9. PubMed ID: 14081730
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between tyramine and iproniazid on guinea-pig atria.
    Garcia de Jalón PD; Martinez-Sierra R; Velasco A
    Br J Pharmacol; 1973 Aug; 48(4):609-11. PubMed ID: 4788204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.